Thyroid hormone imbalance leading to neurodevelopmental abnormalities (Homo sapiens)
From WikiPathways
Description
Adverse Outcome Pathway for the effect of thyroid hormone disruption
Please use the New WikiPathways
View approved pathways at the new wikipathways.org. This website will shutdown soon.Quality Tags
Ontology Terms
Bibliography
- Sauer UG, Asiimwe A, Botham PA, Charlton A, Hallmark N, Jacobi S, Marty S, Melching-Kollmuss S, Palha JA, Strauss V, van Ravenzwaay B, Swaen G; ''Toward a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny - part I: which parameters from human studies are most relevant for toxicological assessments?''; Crit Rev Toxicol, 2020 PubMed Europe PMC Scholia
- Marty S, Beekhuijzen M, Charlton A, Hallmark N, Hannas BR, Jacobi S, Melching-Kollmuss S, Sauer UG, Sheets LP, Strauss V, Urbisch D, Botham PA, van Ravenzwaay B; ''Towards a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny - part II: how can key events of relevant adverse outcome pathways be addressed in toxicological assessments?''; Crit Rev Toxicol, 2021 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
| View all... |
| Name | Type | Database reference | Comment |
|---|---|---|---|
| BDNF signaling pathway | Pathway | WP2380 (WikiPathways) ![]() | |
| GABA receptor signaling pathway | Pathway | WP4159 (WikiPathways) ![]() | |
| Hippocampal synaptogenesis and neurogenesis | Pathway | WP5231 (WikiPathways) ![]() | |
| KE1656: Thyroid Receptor antagonism | |||
| KE2104: Decreased binding TH to Thyroid Receptor | |||
| KE2105: Decreased myelin basic protein expression in oligodendrocytes | |||
| KE2106: Impaired oligodendrocyte maturation | |||
| KE2107: Hypomyelination | |||
| KE2108: Altered white brain matter | |||
| KE277: Decrease thyroid hormone synthesis | Key Event | 277 (AOP-Wiki KE) ![]() | |
| KE279: Thyroperoxidase inhibition | Key Event | 279 (AOP-Wiki KE) ![]() | |
| KE280:Decreased T4 in neuronal tissue | Key Event | 280 (AOP-Wiki KE) ![]() | |
| KE281:Decreased T4 in serum | Key Event | 281 (AOP-Wiki KE) ![]() | |
| KE319: loss of cochlear function | Key Event | 319 (AOP-Wiki KE) ![]() | |
| KE341: Learning and memory impairment | Key Event | 341 (AOP-Wiki KE) ![]() | |
| KE381:Reduced levels of BDNF | Key Event | 381 (AOP-Wiki) ![]() | |
| KE385: Decreased synaptogenesis | Key Event | 385 (AOP-Wiki KE) ![]() | |
| KE386: Decreased neuronal network function | Key Event | 386 (AOP-Wiki KE) ![]() | |
| KE424: NIS inhibition | Key Event | 424 (AOP-Wiki KE) ![]() | |
| KE425: Decrease of Thyroidal Iodide | Key Event | 425 (AOP-Wiki KE) ![]() | |
| KE42: Decreased cognitive function | Key Event | 42 (AOP-Wiki KE) ![]() | |
| KE756:Altered hippocampal gene expression | Key Event | 756 (AOP-Wiki KE) ![]() | |
| KE757: Altered hippocampal anatomy | Key Event | 757 (AOP-Wiki KE) ![]() | |
| KE758: Altered hippocampal physiology | Key Event | 758 (AOP-Wiki KE) ![]() | |
| KE851: Decreased GABAergic interneurons | Key Event | 851 (AOP-Wiki KE) ![]() | |
| Oligodendrocyte specification and differentiation, leading to myelin components for CNS | Pathway | WP4304 (WikiPathways) ![]() | |
| Thyroid hormone biosynthesis pathway | Pathway | WP1981 (WikiPathways) ![]() |
Annotated Interactions
No annotated interactions
Saving...

